Accolate prices near Ashburn, VA
Lowest: $93.52 Highest: $111.13
Est. Cash Price: $104.99
$93.52 (Qty: 60)
Est. Cash Price: $107.50
$101.97 (Qty: 60)
What is Accolate?
USES: Zafirlukast is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma. Controlling symptoms of asthma helps you maintain your normal activities and cuts down on time lost from work or school. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, salbutamol) as prescribed.
How to take Accolate
HOW TO USE: Read the Patient Information Leaflet if available from your pharmacist before you start taking zafirlukast and each time you get a refill. If you have any questions, ask your doctor or pharmacist. Take this medication by mouth without food as directed by your doctor, usually 2 times daily. Take zafirlukast on an empty stomach at least 1 hour before or 2 hours after meals. The dosage is based on your age. Use this medication regularly to get the most benefit from it. To help you remember, take it at the same times each day. Keep taking this medication even if you feel well. Do not increase your dose, use this drug more often, or stop using it without first consulting your doctor. Get medical help right away if your asthma symptoms worsen or if you are using your quick-relief inhaler more than usual or more often than prescribed.
What if I miss a dose of Accolate?
MISSED DOSE: If you miss a dose, take it as soon as you remember. If it is near the time of the next dose, skip the missed dose. Take your next dose at the regular time. Do not double the dose to catch up.
STORAGE: Store at room temperature away from light and moisture. Do not store in the bathroom. Keep all medications away from children and pets. Do not flush medications down the toilet or pour them into a drain unless instructed to do so. Properly discard this product when it is expired or no longer needed. Consult your pharmacist or local waste disposal company.
Side Effects of Accolate
SIDE EFFECTS: Remember that your doctor has prescribed this medication because he or she has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects. Tell your doctor right away if you have any serious side effects, including: mental/mood changes (such as trouble sleeping, agitation, hallucinations, depression, thoughts of suicide), signs of infection (such as sore throat that doesn't go away, fever, cough), numbness/tingling of arms/legs, chest pain, coughing up blood, worsening shortness of breath, muscle/joint pain, swelling ankles/feet. This drug may rarely cause serious (possibly fatal) liver disease. Get medical help right away if you have any symptoms of liver damage, such as: nausea/vomiting that doesn't stop, loss of appetite, stomach/abdominal pain, yellowing eyes/skin, dark urine. A very serious allergic reaction to this drug is rare. However, get medical help right away if you notice any symptoms of a serious allergic reaction, including: rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing. This is not a complete list of possible side effects. If you notice other effects not listed above, contact your doctor or pharmacist. In the US - Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or at www.fda.gov/medwatch. In Canada - Call your doctor for medical advice about side effects. You may report side effects to Health Canada at 1-866-234-2345.
Interactions with Accolate
DRUG INTERACTIONS: Drug interactions may change how your medications work or increase your risk for serious side effects. This document does not contain all possible drug interactions. Keep a list of all the products you use (including prescription/nonprescription drugs and herbal products) and share it with your doctor and pharmacist. Do not start, stop, or change the dosage of any medicines without your doctor's approval. Other medications can affect the removal of zafirlukast from your body, which may affect how zafirlukast works. An example is erythromycin, among others. This medication can slow down the removal of other medications from your body, which may affect how they work. An example is warfarin, among others.
PRECAUTIONS: Before taking zafirlukast, tell your doctor or pharmacist if you are allergic to it; or if you have any other allergies. This product may contain inactive ingredients, which can cause allergic reactions or other problems. Talk to your pharmacist for more details. Before using this medication, tell your doctor or pharmacist your medical history, especially of: liver disease, alcohol use. Before having surgery, tell your doctor or dentist about all the products you use (including prescription drugs, nonprescription drugs, and herbal products). Older adults may be more sensitive to the side effects of this drug. During pregnancy, this medication should be used only when clearly needed. Discuss the risks and benefits with your doctor. This medication passes into breast milk. Consult your doctor before breast-feeding.
Conditions Commonly Treated by Accolate
Prescription prices may vary from pharmacy to pharmacy and are subject to change. The pricing estimates given are based on the most recent information available and may change based on when you actually fill your prescription at the pharmacy. The day supply is based upon the average dispensing patterns or the specific drug and strength. The Program, as well as the prices and the list of covered drugs, can be modified at any time without notice.
Blog Posts Related to Accolate
The cold wintery weather can be the cause or trigger for a variety of health issues and problems. Everyday complaints such as the common cold and flu are more frequent, as are hospital acquired infections and viral infections such as norovirus. The cold months of the year also bring a higher risk...
GlaxoSmithKline (GSK) has issued a voluntary Class II recall for three batches of its Ventolin HFA 200D inhalers, totaling over 593,000 units. The recall only affects hospitals, pharmacies, wholesalers and retailers and will not require patients to return their medication. Ventolin inhalers are...
Patients taking medication for asthma have been reminded to keep up-to-date with vaccinations against pneumococcal disease. The Asthma and Allergy Foundation of America (AAFA) released the warning following a survey, which revealed many at-risk patients with asthma were unaware of their vaccination...
Half the respondents to a recent survey are aware of what pneumococcal disease is, but less than one-third were vaccinated against the condition. The poll, conducted by the Asthma and Allergy Foundation of America (AAFA), revealed a significant proportion of at-risk respondents were not immunized...
The US Food and Drug Administration (FDA) has approved a new once-daily single inhaler triple therapy for treatment of certain adults with chronic obstructive pulmonary disease (COPD).
Trelegy Ellipta (furoate, umeclidinium, vilanterol) is indicated for patients on a fixed-dose combination...
The US Food and Drug Administration (FDA) has approved Sunovion’s Lonhala Magnair (glycopyrrolate), making it the first nebulized long-acting muscarinic antagonist (LAMA) treatment in the United States for patients with chronic obstructive pulmonary disease (COPD). It is expected to appear in...
Asthma management among children has improved in recent years, with a smaller percentage of children hospitalized as a result of the condition, according to the latest Vital Signs report from the Centers for Disease Control and Prevention (CDC).
Since the last study, the percentage of...
GlaxoSmithKline’s once-daily triple therapy, the Trelegy Ellipta (fluticasone furoate, umeclidinium, vilanterol), is superior to dual combination therapies in reducing exacerbations in patients with chronic obstructive pulmonary disease (COPD) with a history of exacerbations, new research...
A new treatment option will soon be available for children aged five and over with asthma following the US Food and Drug Administration’s (FDA) decision to expand its approval of the GlaxoSmithKline (GSK) Arnuity Ellipta (fluticasone furoate) inhaler.
The medication was first approved...
Similar Drugs to Accolate and Other Antileukotriene Anti-asthmatics, Systemic